Citadel Advisors’s Viveon Health Acquisition Corp. VHAQ Stock Holding History
Bought
Maintained
Sold
Other funds holding VHAQ
MI
SCM
PAMP
FTCM
GCL
PC
MSU
SFM
CIM
Citadel Advisors's VHAQ Position: Q1 2022 in Review
Citadel Advisors sold out of Viveon Health Acquisition Corp. (VHAQ) in Q1 2022, closing a stake of 15,293 shares — an estimated $153K sold.
Citadel Advisors first reported a position in VHAQ in Q3 2021 and held it in 2 quarters. The position peaked at $153K in Q4 2021. 27 funds tracked by Wall St. Rank hold VHAQ as of Q1 2022.
- Citadel Advisors reported no remaining Viveon Health Acquisition Corp. position as of Q1 2022 after selling out during the quarter.
- Citadel Advisors sold 15,293 Viveon Health Acquisition Corp. shares in Q1 2022, an estimated $153K.
- Citadel Advisors first reported a position in Viveon Health Acquisition Corp. in Q3 2021 and held it in 2 quarters.
- Citadel Advisors's Viveon Health Acquisition Corp. position peaked at $153K in Q4 2021.
- 27 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. as of Q1 2022.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.